Alfa Cytology

Personalized Services and Customized Solutions

ABOUT US

Alfa Cytology employs the latest research technology.

Scientific Excellence

Customized Solutions

Collaborative Approach

Confidentiality and Data Security

CONTACT US

Most Common Cancers

Explore our solutions to gain a deeper understanding of specific diseases and drive advancements in cancer resarch.

Eye Cancer

Learn about our research services dedicated to understanding and treating eye cancers, with a focus...

Gynecologic Cancer

Discover our comprehensive range of services for gynecologic cancer research, offering advanced...

Head and Neck Cancer

Learn about our cutting-edge solutions for studying and combating head and neck cancers, providing...

Lung Cancer

Explore our research services focused on understanding and addressing lung cancers...

Skin Cancer

Discover our expertise in skin cancer research, offering advanced diagnostic tools, molecular...

Bladder Cancer

Learn how our comprehensive range of services can support bladder cancer research, providing valuable...

Blood Cancer

Discover our specialized services tailored to studying cancers of the lymphatic system and blood...

Sarcomas

Learn about our cutting-edge solutions for studying and combating bone and soft tissue cancers...

Brain and Nervous System Cancer

Explore our services focused on understanding and addressing brain and nervous system cancers...

Breast Cancer

Learn how our comprehensive range of services can support breast cancer research, from biomarker discovery...

Gastrointestinal Cancer

Discover our expertise in gastrointestinal cancer research, providing valuable insights into...

Thyroid Cancer

Explore our specialized services for studying thyroid cancer, including hormone-based therapies...

Targets and Pathways

From immune checkpoint inhibitors to growth inhibitors and metabolic modulators, we are dedicated to advancing the field of cancer therapy.

Immune Checkpoint Inhibitors

We specialize in developing therapies that target immune checkpoints, such as PD-1, PD-L1, and CTLA-4, to enhance the body's immune response to cancer cells.

Cancer Growth Inhibitors

Our services focus on the development of growth inhibitors to disrupt cancer cell growth pathways, e.g., CDK, VEGF-VEGFR, PI3K/AKT/mTOR pathway, PARP, and disrupt tumor cell survival.

Cytokine and Chemokine Pathway Inhibitors

Our company is dedicated to the development of cytokine and chemokine pathway inhibitors that inhibit angiogenesis and interfere with tumor cell metabolism, e.g., inhibition of TNF-α, IL-1, IL-6, chemokine receptors, etc.

Protein Kinase Inhibitors

We offer expertise in developing inhibitors that target specific protein kinases implicated in cancer, e.g., EGFR, HER2, ALK .

Cancer Stem Cells Inhibitors

Our company focuses on the development of tumor stem cell inhibitors, with a particular focus on key signaling pathway inhibitors such as Notch and Wnt.

TAM Modulators

Our company is deeply engaged in the research field of TAM modulator, especially in the three key targets of AXL, MER and TYRO3.

NK Modulators

In our company's scientific research, the study of NK modulators has been at the core of our research, especially on a series of key targets such as NKG2D, NKp30, NKp44, NKp46, NKG2A, and KIR.

IAP Inhibitors

IAP Inhibitors research has always been at the core of our company's research, and we have focused on the in-depth study of key targets such as XIAP, cIAP1, and the NF-κB pathway.

Autophagy Inhibitors

In the field of autophagy modulator research, our company has a deep professional background and unique technical advantages, with a special focus on key targets such as VPS34, ATG, mTOR and Beclin 1.

Multiple Molecule Types

From small molecule drugs and therapeutic antibodies to cell-based therapies and gene therapies, we offer comprehensive support for the development of innovative treatments.

Small Molecule

Our services encompass target identification, lead optimization, medicinal chemistry, and preclinical evaluation of small molecule drugs.

Therapeutic Antibody

Our services include antibody discovery, engineering, optimization, and production, with the aim of developing targeted and immunotherapeutic approaches to cancer treatment.

Cell Therapy

Our expertise lies in the development and optimization of cell therapies, contributing to the advancement of personalized and immunotherapeutic strategies against cancer.

Gene Therapy

Our services cover gene delivery systems, gene editing technologies, and the development of viral vectors to enable precise and targeted interventions in cancer cells.

Cancer Vaccine

Our services encompass antigen selection, vaccine design, and immunogenicity evaluation, contributing to the development of preventive and therapeutic cancer vaccines.

Peptide Therapeutics

Our expertise includes peptide design, synthesis, modification, and pharmacological evaluation, enabling the development of tailored and targeted peptide therapeutics.

Our Innovative Services

We offer a range of specialized services tailored to each phase, enabling comprehensive exploration and advancement in the field of oncology.

Cancer Basic Research Services Cancer Diagnostic Development Services Cancer Modeling Services Cancer Drug Development Services Preclinical Research Services

CONTACT US

Explore Our Resources

From case studies to industry reports, dive into a wealth of resources curated to enhance your understanding of cutting-edge developments in oncology and streamline your journey towards impactful discoveries.

Brochure

miRNA Profiling in DEN-Induced Mouse Model of Primary Hepatocellular Carcinogenesis

LEARN MORE

Brochure

Innovative ADC Therapeutics Development for Breast Cance

LEARN MORE

Brochure

Designing Your Preclinical Cancer Modeling Mouse Studies

LEARN MORE

Brochure

How to Select the Right Service Provider for Cancer Therapy Development

DOWNLOAD

Flyer

PARP Inhibitor Development Based on PDX Models

LEARN MORE

Brochure

High-Throughput Screening (HTS) Platform for Pancreatic Cancer Drug Discovery

DOWNLOAD

Flyer

End-to-End Leukemia Therapy Development Platform

DOWNLOAD

Get in Touch

Send us a message, we will respond soon.

Contact Details

Location

Send Your Email

Phone Number

Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.

Important Links

By Molecule Type